Strides Arcolab receives 5th HIV products approval from WHO

New Delhi, July 4 (UNI) Strides Arcolab Ltd today announced that the World Health Organization (WHO) has included its generic fixed dose combination of Anti-HIV drug Lamivudine/Zidovidine in its list of pre-qualified suppliers.

Prior to this approval, the company has four HIV drugs in the WHO pre-qualified list.

An additional three products have been submitted for pre-qualification, which will complete a comprehensive product offering from the company, a statement said.

UNI DKS RA RK1842